$345 Million is the total value of Monashee Investment Management LLC's 38 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AN2 THERAPEUTICS INC | $6,530,000 | – | 433,330 | +100.0% | 1.89% | – | |
| SEDG | New | SOLAREDGE TECHNOLOGIES INC | $6,447,000 | – | 20,000 | +100.0% | 1.87% | – |
| SWX | New | SOUTHWEST GAS HOLDINGS INC | $5,872,000 | – | 75,000 | +100.0% | 1.70% | – |
| PLL | New | PIEDMONT LITHIUM LTD-ADR | $2,920,000 | – | 40,000 | +100.0% | 0.85% | – |
| New | ARCHAEA ENERGY INC | $2,851,000 | – | 130,000 | +100.0% | 0.83% | – | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $2,577,000 | – | 100,000 | +100.0% | 0.75% | – |
| NARI | New | INARI MEDICAL INC | $2,266,000 | – | 25,000 | +100.0% | 0.66% | – |
| ACI | New | ALBERTSONS COS INC - CLASS A | $1,995,000 | – | 60,000 | +100.0% | 0.58% | – |
| HESM | New | HESS MIDSTREAM LP - CLASS A | $1,800,000 | – | 60,000 | +100.0% | 0.52% | – |
| ATHA | New | ATHIRA PHARMA INC | $1,350,000 | – | 100,000 | +100.0% | 0.39% | – |
| NWN | New | NORTHWEST NATURAL GAS CO | $1,293,000 | – | 25,000 | +100.0% | 0.37% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $1,248,000 | – | 24,555 | +100.0% | 0.36% | – |
| New | REVELATION BIOSCIENCES INC | $932,000 | – | 817,562 | +100.0% | 0.27% | – | |
| KREF | New | KKR REAL ESTATE FINANCE TRUS | $870,000 | – | 42,220 | +100.0% | 0.25% | – |
| New | KINETIK HOLDINGS INC | $551,000 | – | 8,500 | +100.0% | 0.16% | – | |
| TWST | New | TWIST BIOSCIENCE CORP | $494,000 | – | 10,000 | +100.0% | 0.14% | – |
| CDTX | New | CIDARA THERAPEUTICS INC | $307,000 | – | 369,099 | +100.0% | 0.09% | – |
| MQ | New | MARQETA INC-A | $166,000 | – | 15,000 | +100.0% | 0.05% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $93,000 | – | 10,000 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
| VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
| SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
| BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
| COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
| BIOMX INC | 8 | Q3 2021 | 0.0% |
| AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
| COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
| WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
| FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-07 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.